0
Home
News
Directory
E-newsletter
Magazine
Events
Data
AgReport
Subscribe
Bayer releases glyphosate safety reports for transparency
Apr. 10, 2019
Related News
- Bayer raises the bar in transparency, sustainability and engagement
- Glyphosate loses support in Costa Rica
- Bayer to comply with court ordered mediation in California glyphosate lawsuit
- US jury says Bayer must pay $80 million to man in Roundup cancer trial
- US California Jury Finds Roundup Caused Man’s Cancer
With recent legal battles, Bayer is even more dedicated to the transparency of glyphosate by releasing safety study reports. Bayer welcomes a science-based discussion with regulators around the globe, the international research community, as well as with consumers on the safety profile of glyphosate. To that end, all 107 Bayer-owned glyphosate safety study reports that were submitted to the European Food Safety Authority as part of the substance authorization process in the European Union are now accessible on Bayer’s dedicated transparency platform.
In doing so, the company delivers on its commitment to more transparency, including its crop protection safety studies following the acquisition of Monsanto. Many of these and other similar studies were submitted to and evaluated by the U.S. Environmental Protection Agency during its own risk assessment of glyphosate.
“Transparency is a catalyst for trust, so more transparency is a good thing for consumers, policymakers, and businesses. As an innovation company, safety is our top priority and we are completely committed to doing everything we can to ensure that our products are safe for people and the environment,” said Liam Condon, member of the Board of Management of Bayer AG and president of the Crop Science Division. “By making our detailed scientific safety data available, we encourage anyone interested to see for themselves how comprehensive our approach to safety is. We embrace the opportunity to engage in dialogue so we can build more trust in sound science.”
This new addition to the Bayer Transparency platform follows last December’s publication of more than 300 glyphosate safety study summaries submitted under the EU substance authorization process for plant protection products. Access has now been enabled to all the related in-depth glyphosate safety studies to which Bayer wholly owns the rights. Due to legal restrictions, Bayer cannot release the glyphosate studies conducted and owned by third parties.
Source: agdaily
More from AgroNews
Change
Hot TopicSubscribe
| Subscribe Email: | * | |
| Name: | ||
| Mobile Number: | ||
Comment
0/1200
NEWSLETTER